Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-06-15IMVT144Atul Pande plan to sell securities of IMMUNOVANT, INC. under Form 144MEDIUM
Atul Pande filed Form 144 to notify SEC of plan to sell 6000 units of IMMUNOVANT, INC. securities around 2026-06-15, with aggregate market value of $201,720.00. The total outstanding units is 205308917.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months inc...
Mid CapBiotechnology
2026-06-15CVKD144Quang X. Pham plan to sell securities of CADRENAL THERAPEUTICS, INC. under Form 144MEDIUM
Quang X. Pham filed Form 144 to notify SEC of plan to sell 40000 units of CADRENAL THERAPEUTICS, INC. securities around 2026-06-15, with aggregate market value of $148,400.00. The total outstanding units is 2868247.0. The amount planned to be sold represents 1.39% of total outstanding units; Recent transactions in past...
Nano CapBiotechnology
2026-06-15ABOS144DERRELL PORTER plan to sell securities of ACUMEN PHARMACEUTICALS, INC. under Form 144MEDIUM
DERRELL PORTER filed Form 144 to notify SEC of plan to sell 6460 units of ACUMEN PHARMACEUTICALS, INC. securities around 2026-06-15, with aggregate market value of $15,148.70. The total outstanding units is 72227580.0. The amount planned to be sold represents 0.01% of total outstanding units; ...
Micro CapBiotechnology
2026-06-15ARDX144MICHAEL RAAB plan to sell securities of ARDELYX INC under Form 144MEDIUM
MICHAEL RAAB filed Form 144 to notify SEC of plan to sell 125000 units of ARDELYX INC securities around 2026-06-15, with aggregate market value of $711,250.00. The total outstanding units is 247029387.0. The amount planned to be sold represents 0.05% of total outstanding units; Recent transactions in past 3 months incl...
Small CapBiotechnology
2026-06-15ADPT144Harlan Robins plan to sell securities of Adaptive Biotechnologies Corporation under Form 144MEDIUM
Harlan Robins filed Form 144 to notify SEC of plan to sell 100000 units of Adaptive Biotechnologies Corporation securities around 2026-06-15, with aggregate market value of $1,746,000.00. The total outstanding units is 160044392.0. The amount planned to be sold represents 0.06% of total outstanding units; Recent transa...
Mid CapBiotechnology
2026-06-15MLTX144Reich Kristian plan to sell securities of MoonLake Immunotherapeutics under Form 144MEDIUM
Reich Kristian filed Form 144 to notify SEC of plan to sell 150000 units of MoonLake Immunotherapeutics securities around 2026-06-15, with aggregate market value of $2,850,000.00. The total outstanding units is 73615396.0. The amount planned to be sold represents 0.20% of total outstanding units; ...
Small CapBiotechnology
2026-06-15MLYS144Rodman David Malcom plan to sell securities of Mineralys Therapeutics, Inc. under Form 144MEDIUM
Rodman David Malcom filed Form 144 to notify SEC of plan to sell 9890 units of Mineralys Therapeutics, Inc. securities around 2026-06-15, with aggregate market value of $235,487.24. The total outstanding units is 82498101.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions ...
Mid CapBiotechnology
Sponsored